K
Kyverna Therapeutics, Inc.
KYTX · NASDAQ · Healthcare · 497M
Price · close
$8.42
+3.57% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.6×
Enterprise value / EBITDAEV/EBITDA
-1.7×
Free cash flow yieldFCF yield
-41.2%
Return on equityROE
-69.4%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.6×
Interest coverage
-347.3×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.